THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,180 | +39.4% | 252,609 | +67.1% | 0.02% | +108.3% |
Q2 2023 | $1,564 | +379.8% | 151,134 | +403.6% | 0.01% | +200.0% |
Q1 2023 | $326 | +88.4% | 30,008 | +94.8% | 0.00% | +100.0% |
Q4 2022 | $173 | -99.9% | 15,407 | -43.5% | 0.00% | -33.3% |
Q3 2022 | $276,000 | +72.5% | 27,265 | +54.1% | 0.00% | +50.0% |
Q2 2022 | $160,000 | -33.3% | 17,698 | -18.5% | 0.00% | +100.0% |
Q4 2021 | $240,000 | -16.7% | 21,711 | -44.3% | 0.00% | 0.0% |
Q3 2021 | $288,000 | +146.2% | 38,968 | +384.6% | 0.00% | 0.0% |
Q2 2021 | $117,000 | -84.4% | 8,042 | -81.0% | 0.00% | -75.0% |
Q4 2020 | $750,000 | +114.9% | 42,230 | +153.7% | 0.00% | +33.3% |
Q2 2020 | $349,000 | -46.4% | 16,643 | -40.9% | 0.00% | -50.0% |
Q1 2020 | $651,000 | +317.3% | 28,178 | +366.9% | 0.01% | +500.0% |
Q4 2019 | $156,000 | 0.0% | 6,035 | -12.4% | 0.00% | 0.0% |
Q1 2019 | $156,000 | +20.0% | 6,890 | +28.9% | 0.00% | 0.0% |
Q1 2018 | $130,000 | -58.1% | 5,347 | -41.0% | 0.00% | -66.7% |
Q3 2017 | $310,000 | +31.4% | 9,061 | +52.8% | 0.00% | +50.0% |
Q2 2017 | $236,000 | +16.8% | 5,931 | +8.1% | 0.00% | 0.0% |
Q1 2017 | $202,000 | -70.6% | 5,488 | -74.5% | 0.00% | -66.7% |
Q4 2016 | $686,000 | – | 21,510 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |